All Vaccinology articles – Page 4
-
NewsYellow fever vaccination: how strong immune responses are triggered
Researchers have shown how specific immune cells are activated by the vaccine – an important starting point for the development of new vaccines.
-
NewsNew study offers insights into designing safe, effective nasal vaccines
Researchers found that nasal vaccine boosters can trigger strong immune defenses in the respiratory tract, even without the help of immune-boosting ingredients known as adjuvants. The findings, researchers suggest, may offer critical insights into developing safer, more effective nasal vaccines in the future.
-
NewsNew vaccine protects against swine, human and bird flu
Annual flu shots could become a thing of the past under a new vaccine strategy. A new study describes a vaccine that protects against H1N1 swine flu and can also protect against influenza in humans and birds.
-
NewsResearchers pioneer novel, needle-free, live-attenuated influenza vaccines with broad protection
Researchers have achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV).
-
NewsPredictive AI model can help build vaccines for future versions of a virus
Researchers have created an AI tool called EVE-Vax that can predict and design viral proteins likely to emerge in the future. For SARS-CoV-2, panels of these “designer” proteins triggered similar immune responses as real-life viral proteins that emerged during the pandemic.
-
NewsGlobal Virus Network meeting unites Caribbean and Latin America to tackle emerging viral threats
A two-day summit focused on collaborative strategies to bolster viral surveillance, diagnostics, vaccine research, and pandemic preparedness across Latin America and the Caribbean, challenges intensified by climate change and globalization.
-
NewsResearchers valuate the safety and efficacy of a smallpox vaccine for preventing mpox
Researchers explored the viability and safety of LC16m8, an attenuated vaccinia virus vaccine, to prevent monkeypox. The study evaluated the immunogenicity and safety of LC16m8 across three animal species.
-
NewsScientists launch intranasal albumin-based vaccine technology platform against respiratory virus
A new paper reports on a novel vaccine technology platform, in which the subunit antigen is genetically fused to albumin. The albumin-antigen fusion vaccines induced both systemic and mucosal antigen-specific antibody responses.
-
NewsPlacebo-testing vaccines is unethical, ‘a waste of time and money,’ expert says
The proposal to require that all new vaccines undergo safety testing in placebo-controlled trials is ethically problematic and will slow testing down for no good reason, warn scientists.
-
NewsPediatric investigation review discusses the challenges, innovations, and future directions in dengue vaccine development
A new review discusses the current status and implications of dengue vaccines like CYD-TDV, TAK-003, and Butantan-DV while exploring the challenges in Dengue vaccine development like ADE, and proposes future directions in this field.
-
NewsCOVID-19 vaccinations are metabolically safe, research finds
New research confirms that multiple doses of COVID-19 vaccines do not cause significant metabolic changes, offering reassurance for those concerned about potential long-term side effects of vaccination.
-
NewsMeasles may be making a comeback in the US, research finds
If immunization rates drop further over a prolonged period of time, measles and even other wiped-out diseases — such as rubella and polio — could one day make a comeback in the United States, according to a new study.
-
NewsEvery dose counts: Safeguarding the success of vaccination in Europe
Marking European Immunization Week (EIW) 2025, a new report highlights the risks of suboptimal vaccination coverage in Europe and publishes a set of operational tools that public health authorities can use to improve vaccination acceptance and uptake.
-
NewsEuropean Immunization Week 2025: Inequalities in immunisation against measles could contribute to outbreaks
Research reveals inequalities in MMR vaccination that may contribute to measles outbreaks and epidemics, emphasising the importance of socioeconomic and demographic data in driving public health efforts.
-
NewsBNT162b2 vaccine not only targets COVID-19 virus, but may also help control innate inflammation
New findings suggest the BNT162b2 vaccine may reduce the production of pro-inflammatory mediators to bacterial, fungal or viral infections by reprogramming innate immune cells to regulate inflammation.
-
NewsStudy: Experimental bird flu vaccine excels in animal models
A vaccine has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. It focuses on the H5N1 variant known as 2.3.4.4b, which has caused widespread outbreaks in wild birds and poultry.
-
NewsDr. Sabine Ehrt named Chair of the Department of Microbiology and Immunology at Weill Cornell Medicine
Dr. Sabine Ehrt, an internationally renowned leader in tuberculosis research, has been appointed chair of the Department of Microbiology and Immunology at Weill Cornell Medicine.
-
NewsExperts stress importance of vaccination amidst measles outbreaks
Pediatric infectious diseases experts stress the importance of vaccination against measles, one of the most contagious viruses, which is once more spreading in the United States.
-
NewsInvesting in COVID-19 vaccination more than paid off for U.S., study finds
The US national Covid-19 vaccine strategy more than paid for itself after just one year, according to a new study. Because the vaccines reduced how many people developed serious illness or died, the nation saved more money than it spent.
-
NewsCOVID-19 vaccination induces long-lasting antibody B-cell responses
A research study revealed that memory B cells maintain long-lasting and stable responses prior to mRNA vaccinations for COVID-19, but updated vaccines targeting new variants could boost immunity.